Brief Title
Surgical Versus Medical Treatment of Acromegaly
Official Title
Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers
Brief Summary
Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone). Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.
Study Type
Observational
Condition
Acromegaly
Study Arms / Comparison Groups
Acromegaly patients, somatostain analogues
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
63
Start Date
October 2009
Completion Date
June 2011
Primary Completion Date
February 2010
Eligibility Criteria
Inclusion Criteria: - Acromegaly diagnosis - treated with Somatostatin analogues or surgery - in treatment control Exclusion Criteria: - treatment with GH-antagonist - never treated - not in treatment control
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Kristine Z Rubeck, stud. med., ,
Location Countries
Denmark
Location Countries
Denmark
Administrative Informations
NCT ID
NCT01000090
Organization ID
kzr200809
Responsible Party
Sponsor
Study Sponsor
University of Aarhus
Study Sponsor
Kristine Z Rubeck, stud. med., Study Director, Medical department M, Århus University Hospital
Verification Date
June 2011